Cambridge Investment Research Advisors Inc. boosted its holdings in shares of Aetna Inc (NYSE:AET) by 7.6% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 40,267 shares of the company’s stock after acquiring an additional 2,833 shares during the period. Cambridge Investment Research Advisors Inc.’s holdings in Aetna were worth $7,264,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Focused Wealth Management Inc grew its holdings in Aetna by 84.5% during the 4th quarter. Focused Wealth Management Inc now owns 655 shares of the company’s stock worth $118,000 after acquiring an additional 300 shares during the period. Cerebellum GP LLC acquired a new stake in Aetna during the 4th quarter worth $125,000. James Hambro & Partners acquired a new stake in Aetna during the 4th quarter worth $158,000. Harel Insurance Investments & Financial Services Ltd. acquired a new stake in Aetna during the 4th quarter worth $180,000. Finally, Signature Estate & Investment Advisors LLC acquired a new stake in Aetna during the 4th quarter worth $182,000. 87.25% of the stock is owned by hedge funds and other institutional investors.
A number of analysts have commented on AET shares. Credit Suisse Group lifted their target price on shares of Aetna from $200.00 to $208.00 and gave the stock a “neutral” rating in a report on Wednesday, January 31st. Jefferies Group reaffirmed a “hold” rating and set a $205.00 target price on shares of Aetna in a report on Wednesday, January 31st. Argus lowered shares of Aetna from a “buy” rating to a “hold” rating and set a $185.00 target price for the company. in a report on Wednesday, December 6th. Cowen reaffirmed a “buy” rating and set a $212.00 target price on shares of Aetna in a report on Tuesday, January 30th. Finally, Piper Jaffray Companies reissued a “buy” rating and issued a $212.00 price target on shares of Aetna in a report on Tuesday, January 30th. Nine research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $189.50.
Aetna (NYSE:AET) last posted its quarterly earnings data on Tuesday, January 30th. The company reported $1.25 EPS for the quarter, beating the consensus estimate of $1.18 by $0.07. The business had revenue of $14.74 billion for the quarter, compared to analysts’ expectations of $14.79 billion. Aetna had a net margin of 3.15% and a return on equity of 21.50%. The firm’s revenue was down 6.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.08 EPS. equities analysts predict that Aetna Inc will post 11.06 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 27th. Investors of record on Thursday, April 12th will be given a $0.50 dividend. The ex-dividend date is Wednesday, April 11th. This represents a $2.00 annualized dividend and a yield of 1.19%. Aetna’s dividend payout ratio is currently 34.78%.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.